Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Ixekizumab effectively treats generalized pustular psoriasis.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Certain gene variations are linked to alopecia areata.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

BST2 is a key marker for hair loss disease alopecia areata.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

IL-1 alpha stops hair follicle growth and hair production.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

QLT0267 stops hair follicle cell growth and movement.

UV exposure reduces Lgr6+ stem cells in mouse skin and they don't significantly contribute to skin cancer development.

HPV8 E6 gene causes growth of certain skin stem cells.

Salivary vitamin D and IL-6 could help diagnose and manage non-scarring alopecia.

BST2 protein and certain T cells increase in early alopecia areata.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

ILC1 cells contribute to hair loss in alopecia areata.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Four specific genes are linked to keloid formation and could be potential treatment targets.